GlassScriptPhysician profile
Michael Dale Foreman
NPI 1609852474
$1,560.79
in general payments reported to CMS, 2019-2025
16 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $139 · 2021: $159 · 2022: $295 · 2023: $346 · 2024: $185 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.04 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $548.24 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $231.21 | 2023-2025 | Myfembree |
| Organon LLC | $134.89 | 2021-2024 | Nexplanon |
| Pfizer INC. | $128.74 | 2019-2025 | |
| Sage Therapeutics, LLC | $106.69 | 2024-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $94.38 | 2020-2022 | |
| Shield Therapeutics INC | $61.39 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $51.10 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $45.14 | 2023 | Dupixent |
| Daiichi Sankyo INC. | $33.91 | 2019-2022 | |
| Stryker Corporation | $29.27 | 2019 | |
| Avion Pharmaceuticals | $27.34 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2022 | |
| Millicent US INC | $17.52 | 2025 | Femlyv |
| Pacira Pharmaceuticals Incorporated | $16.11 | 2024 | Exparel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.88 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.